Inflammatory Bowel Disease Treatment Market Size Predicted To Hit USD 34.5 Billion By 2031 At 5.1% CAGR, Says AMR
Rise in prevalence of ulcerative colitis and Crohn's disease, growing awareness of the disease across the world, drives the growth of the market David Correa Allied Market Research + 1 800-792-5285 ...
Rolling Out14h
Ulcerative colitis and its impact on daily life
Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...
gastroenterologyadvisor1d
Severe Histologic Disease Activity in UC Raises Risk of Biologic-Associated Colectomy
Baseline histologic activity predicted colectomy risk in ulcerative colitis treated with biologics, independent of clinical or endoscopic factors.
Jewish Press1d
Targeted mRNA Therapy Holds Promise for Crohn’s Disease, Colitis, and Beyond
The findings suggest that lipid composition can direct mRNA-based drugs to target organs, such as the intestines, without passing through the liver.
EurekAlert!2d
Researchers successfully deliver mRNA-based drugs to the intestine – without passing through the liver
Researchers at Tel Aviv University have achieved a major breakthrough in drug delivery: they have successfully transported lipid nanoparticles encapsulating messenger RNA (mRNA) to the immune system ...
The American Journal of Managed Care6d
FDA Approves Mirikizumab for Crohn Disease
The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...